These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 19681122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.
    Lemesle G, De Labriolle A, Bonello L, Syed A, Collins S, Maluenda G, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R.
    Catheter Cardiovasc Interv; 2009 Sep 01; 74(3):428-35. PubMed ID: 19360860
    [Abstract] [Full Text] [Related]

  • 3. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use.
    Kini AS, Rafael OC, Sarkar K, Rajdev S, Jakkula M, Mares AM, Kaplish D, Krishnan P, Kim MC, Sharma SK.
    Catheter Cardiovasc Interv; 2009 Nov 01; 74(5):700-7. PubMed ID: 19496119
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regarding changing outcomes and treatment strategies for wire-induced coronary perforations in the era of bivalirudin use. A word of caution concerning the use of bivalirudin during coronary intervention for lesions at high risk for perforation.
    Movahed MR.
    Catheter Cardiovasc Interv; 2011 Feb 15; 77(3):456; author reply 457-8. PubMed ID: 21328688
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.
    Iijima R, Ndrepepa G, Mehilli J, Byrne RA, Schulz S, Neumann FJ, Richardt G, Berger PB, Schömig A, Kastrati A.
    Eur Heart J; 2009 Feb 15; 30(3):290-6. PubMed ID: 19147609
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Failed pericardiocentesis for acute cardiac tamponade: two cases associated with bivalirudin administration during PCI.
    Al Shammeri OM, Crowell R, Stewart K, Fort S.
    Catheter Cardiovasc Interv; 2010 Jan 01; 75(1):114-6. PubMed ID: 19626695
    [Abstract] [Full Text] [Related]

  • 10. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
    Steinberg DH, Shah P, Kinnaird T, Pinto Slottow TL, Roy PK, Okabe T, Bonello L, de Labriolle A, Smith KA, Torguson R, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2008 Jul 15; 102(2):160-4. PubMed ID: 18602514
    [Abstract] [Full Text] [Related]

  • 11. Side branch jailing: should we worry?
    Belardi JA.
    Catheter Cardiovasc Interv; 2010 Dec 01; 76(7):958-9. PubMed ID: 21108372
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Let it be, let it be.
    Butman SM.
    Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):898. PubMed ID: 19455656
    [No Abstract] [Full Text] [Related]

  • 17. Bivalirudin and DES: a PCI strategy that pays.
    Applegate RJ.
    J Invasive Cardiol; 2007 Feb 01; 19(2):69-70. PubMed ID: 17268040
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Percutaneous coronary intervention in nonagenarians: age before beauty?
    Bhatt DL.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):531-2. PubMed ID: 18307234
    [No Abstract] [Full Text] [Related]

  • 20. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, Lalonde T, Kline-Rogers E, O'Donnell M, O'Neill W, Safian R, Moscucci M, Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    J Interv Cardiol; 2007 Jun 01; 20(3):197-203. PubMed ID: 17524111
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.